etoposide has been researched along with naphthoquinones in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 5 (22.73) | 24.3611 |
| 2020's | 3 (13.64) | 2.80 |
| Authors | Studies |
|---|---|
| Adamson, RH; Mead, JA; Sieber, SM | 1 |
| Andrews, PA; Howell, SB; Katz, EJ; Kling, KM; Vick, JS | 1 |
| Aiuchi, T; Cao, J; Hashimoto, S; Ida, Y; Masuda, Y; Miyakoshi, M; Nakajo, S; Nakaya, K; Xu, M | 1 |
| Ding, J; Qing, C; Zhang, JS | 1 |
| Bastow, KF; Krishnan, P | 1 |
| Flynn, PM; Harrison, PL; Hughes, W; Relling, MV; Schuetz, EG; van de Poll, ME | 1 |
| Ding, J; He, XX; Meng, LH; Zhang, JS | 1 |
| Hara, O; Ikegami, S; Iwamatsu, T; Shibata, Y; Yamashita, M | 1 |
| Ding, J; Miao, ZH; Tang, T; Zhang, JS; Zhang, YX | 1 |
| Hwang, HJ; Kim, C; Kim, HJ; Lee, EJ; Lee, HJ; Lee, SK; Park, HJ; Seo, EK; Shin, SH; Suh, ME | 1 |
| Aiuchi, T; Hori, K; Horie, M; Kajimoto, S; Masuda, Y; Nakajo, S; Nakaya, K; Shibayama-Imazu, T; Shima, G | 1 |
| Berzins, K; Grandien, A; Hagstedt, M; Nyakeriga, AM; Perlmann, H; Perlmann, P; Troye-Blomberg, M; Zhivotovsky, B | 1 |
| Cai, Y; Ding, J; Lin, L; Lu, J; Miao, Z | 1 |
| Burt, HM; Higo, T; Hunter, WL; Jackson, JK | 1 |
| Chandna, S; Mathur, R; N Kapoor, P; S Dwarakanath, B | 1 |
| Chen, SB; Gu, LQ; Huang, SL; Huang, ZH; Huang, ZS; Li, D; Ou, JB; Ou, TM; Shen, LL; Tan, JH; Wu, WB | 1 |
| Altieri, DC; Bosari, S; Faversani, A; Lopergolo, A; Moro, GP; Rivadeneira, D; Schultz, DC; Tosi, D; Vaira, V | 1 |
| Huang, J; Liu, B; Lyu, H; Wang, J | 1 |
| Kok, MK; Nakagawa, T; Nishimura, R; Ong, SM; Saeki, K | 1 |
| Dizdar, L; Esposito, I; Ghadimi, MPH; Knoefel, WT; Krieg, A; Schlünder, PM; Vay, C | 1 |
| Labbozzetta, M; Notarbartolo, M; Occhipinti, C; Poma, P; Sajeva, M | 1 |
| Bolívar, J; Chinchilla, N; Durán, AG; Gutiérrez, MT; Macías, FA; Molinillo, JMG; Simonet, AM; Valdivia, MM | 1 |
1 review(s) available for etoposide and naphthoquinones
| Article | Year |
|---|---|
Pharmacology of antitumor agents from higher plants.
Topics: Animals; Antineoplastic Agents, Phytogenic; Aporphines; Camptothecin; Carcinoma, Squamous Cell; Chemical Phenomena; Chemistry; Etoposide; Humans; Leukemia L1210; Leukemia, Experimental; Leukemia, Lymphoid; Maytansine; Melanoma; Naphthoquinones; Nasopharyngeal Neoplasms; Neoplasms; Neoplasms, Experimental; Phenanthrenes; Structure-Activity Relationship; Teniposide; Vinblastine; Vincristine | 1976 |
1 trial(s) available for etoposide and naphthoquinones
| Article | Year |
|---|---|
The effect of atovaquone on etoposide pharmacokinetics in children with acute lymphoblastic leukemia.
Topics: Adolescent; Antifungal Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Atovaquone; Child; Child, Preschool; Cross-Over Studies; Drug Interactions; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Naphthoquinones; Pilot Projects; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
20 other study(ies) available for etoposide and naphthoquinones
| Article | Year |
|---|---|
Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cells.
Topics: Antibiotics, Antineoplastic; Camptothecin; Cell Line; Cisplatin; DNA Topoisomerases, Type I; Drug Interactions; Etoposide; Female; Humans; Naphthoquinones; Novobiocin; Ovarian Neoplasms; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 1990 |
beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide.
Topics: Antineoplastic Agents; Apoptosis; Calcium-Calmodulin-Dependent Protein Kinases; Caspase 3; Caspases; Cell Division; DNA Fragmentation; Drug Screening Assays, Antitumor; Enzyme Activation; Etoposide; fas Receptor; HL-60 Cells; Humans; Naphthoquinones; Nucleic Acid Synthesis Inhibitors; Signal Transduction; Tumor Cells, Cultured | 1999 |
In vitro cytotoxicity of salvicine, a novel diterpenoid quinone.
Topics: Antineoplastic Agents, Phytogenic; Cell Cycle; Etoposide; Female; HL-60 Cells; Humans; Interphase; K562 Cells; Naphthoquinones; Tumor Cells, Cultured; Vincristine | 1999 |
Novel mechanism of cellular DNA topoisomerase II inhibition by the pyranonaphthoquinone derivatives alpha-lapachone and beta-lapachone.
Topics: Colony-Forming Units Assay; DNA Damage; Enzyme Activation; Enzyme Inhibitors; Etoposide; Naphthoquinones; Nucleic Acid Synthesis Inhibitors; Oxidative Stress; Topoisomerase II Inhibitors; Tumor Cells, Cultured | 2001 |
DNA topoisomerase II as the primary cellular target for salvicine in Saccharomyces cerevisiae.
Topics: Cytotoxicity, Immunologic; DNA Topoisomerases, Type II; Etoposide; Naphthoquinones; Saccharomyces cerevisiae | 2001 |
Studies on fertilization in the teleost IV. Effects of aphidicolin and camptothecin on chromosome formation in fertilized medaka eggs.
Topics: Animals; Aphidicolin; Camptothecin; Chromosomes; DNA Polymerase I; DNA Topoisomerases; Etoposide; Fertilization; Meiosis; Mitogen-Activated Protein Kinases; Mitosis; Naphthoquinones; Oryzias; Protein Kinases; Topoisomerase Inhibitors; Zygote | 2002 |
Cytotoxicity, apoptosis induction and downregulation of MDR-1 expression by the anti-topoisomerase II agent, salvicine, in multidrug-resistant tumor cells.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Caspase 1; Caspase 3; Caspase 8; Caspase 9; Caspases; DNA, Complementary; Dose-Response Relationship, Drug; Down-Regulation; Doxorubicin; Drug Resistance, Neoplasm; Electrophoresis, Agar Gel; Etoposide; Flow Cytometry; Humans; Inhibitory Concentration 50; K562 Cells; Models, Chemical; Naphthoquinones; Proto-Oncogene Proteins c-bcl-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vincristine | 2003 |
Cytotoxicity and DNA topoisomerase inhibitory activity of benz[f]indole-4,9-dione analogs.
Topics: Antineoplastic Agents; Cell Line, Tumor; DNA Topoisomerases; DNA, Kinetoplast; DNA, Superhelical; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Etoposide; Humans; Indoles; Inhibitory Concentration 50; Naphthoquinones; Nucleic Acid Conformation; Structure-Activity Relationship; Topoisomerase Inhibitors | 2003 |
Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Antioxidants; Apoptosis; Blotting, Northern; Blotting, Western; Cell Death; Cell Line; Cell Line, Tumor; Coloring Agents; Cytochromes c; Cytosol; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Inhibitors; Etoposide; Gene Expression Regulation; Genetic Vectors; HL-60 Cells; HSP90 Heat-Shock Proteins; Humans; K562 Cells; Mitochondria; Naphthoquinones; Oligonucleotide Array Sequence Analysis; Plasmids; Reactive Oxygen Species; RNA, Small Interfering; Subcellular Fractions; Time Factors; Transfection | 2004 |
Drug-induced death of the asexual blood stages of Plasmodium falciparum occurs without typical signs of apoptosis.
Topics: Animals; Antimalarials; Apoptosis; Atovaquone; Cells, Cultured; Chloroquine; DNA Fragmentation; DNA, Protozoan; Enzyme Inhibitors; Erythrocytes; Etoposide; Flow Cytometry; Humans; In Situ Nick-End Labeling; Malaria, Falciparum; Membrane Potentials; Mitochondrial Membranes; Naphthoquinones; Nitric Oxide Donors; Parasitemia; Penicillamine; Plasmodium falciparum | 2006 |
Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells.
Topics: Acetylcysteine; Antineoplastic Agents; Ascorbic Acid; ATP Binding Cassette Transporter, Subfamily B, Member 1; DNA Breaks, Double-Stranded; Drug Resistance, Multiple; Etoposide; Glutathione; Humans; Hydrogen Peroxide; K562 Cells; Naphthoquinones; Reactive Oxygen Species | 2007 |
Topoisomerase inhibitors as anti-arthritic agents.
Topics: Animals; Antirheumatic Agents; Arthritis, Rheumatoid; Camptothecin; Cattle; Cell Proliferation; Cells, Cultured; Chick Embryo; Chondrocytes; Doxorubicin; Enzyme Inhibitors; Etoposide; Interleukin-1; Naphthoquinones; Neutrophils; Rabbits; Synovial Membrane; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Vitamin K 3 | 2008 |
Peptidyl prolyl isomerase, Pin1 is a potential target for enhancing the therapeutic efficacy of etoposide.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Cell Cycle; Cell Proliferation; DNA Damage; Drug Synergism; Enzyme Inhibitors; Etoposide; Flow Cytometry; Humans; Lung Neoplasms; Micronucleus Tests; Naphthoquinones; NIMA-Interacting Peptidylprolyl Isomerase; Peptidylprolyl Isomerase; Tumor Cells, Cultured; Tumor Stem Cell Assay | 2011 |
Synthesis and evaluation of mansonone F derivatives as topoisomerase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antigens, Neoplasm; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Survival; DNA; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; DNA-Binding Proteins; Drug Screening Assays, Antitumor; Etoposide; Humans; Inhibitory Concentration 50; Lung Neoplasms; Naphthoquinones; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Plasmids; Pyrans; Quinones; Sesquiterpenes; Structure-Activity Relationship; Telomerase; Topoisomerase Inhibitors | 2011 |
Survivin family proteins as novel molecular determinants of doxorubicin resistance in organotypic human breast tumors.
Topics: Alternative Splicing; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Camptothecin; Cell Line, Tumor; Cell Proliferation; Cell Survival; DNA Damage; Doxorubicin; Drug Resistance, Neoplasm; Etoposide; Female; High-Throughput Screening Assays; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; MCF-7 Cells; Naphthoquinones; Paclitaxel; Receptor, ErbB-2; Survivin; Tumor Suppressor Protein p53 | 2014 |
Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Doxorubicin; Drug Synergism; Etoposide; HL-60 Cells; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Leukemia, Myeloid, Acute; Molecular Targeted Therapy; Naphthoquinones; Survivin | 2015 |
YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Bone Neoplasms; Cell Proliferation; Dog Diseases; Dogs; Drug Synergism; Etoposide; Humans; Imidazoles; Mice; Naphthoquinones; Osteosarcoma; Survivin; Xenograft Model Antitumor Assays | 2019 |
Targeting abundant survivin expression in liposarcoma: subtype dependent therapy responses to YM155 treatment.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Female; Follow-Up Studies; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Liposarcoma; Male; Middle Aged; Naphthoquinones; Prognosis; Retrospective Studies; Survival Rate; Survivin; Tumor Cells, Cultured | 2022 |
Antitumor Effect of
Topics: Antineoplastic Agents; Boraginaceae; Carcinoma, Hepatocellular; DNA Topoisomerases, Type II; Etoposide; Humans; Leukemia, Myeloid, Acute; Liver Neoplasms; Naphthoquinones; Oils, Volatile; Reactive Oxygen Species; Topoisomerase II Inhibitors | 2022 |
Biological Activity of Naphthoquinones Derivatives in the Search of Anticancer Lead Compounds.
Topics: Antineoplastic Agents; Cell Line, Tumor; Etoposide; Female; HEK293 Cells; Humans; Naphthoquinones | 2023 |